This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Onepharm Research & Development Gmbh. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Paul Kosma - Innovator in Triterpene Compounds
Introduction
Paul Kosma is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel triterpene compounds. His work focuses on compounds that have potential therapeutic applications.
Latest Patents
Paul Kosma holds a patent for N-hydroxy C29-amide derivatives of oleandrane. This invention encompasses novel triterpene compounds of general formula I, which are suitable for the prevention and/or treatment of diseases mediated by 11 β-HSD. The patent outlines the use of these compounds for preparing a medicament with the aforementioned properties. He has 1 patent to his name.
Career Highlights
Paul Kosma is currently associated with Onepharm Research & Development GmbH, where he continues to innovate in the field of pharmaceutical research. His work is characterized by a commitment to developing effective treatments for various diseases.
Collaborations
Some of his notable coworkers include Christian Stanetty and Dirk Classen-Houben. Their collaborative efforts contribute to the advancement of research and development in their field.
Conclusion
Paul Kosma's contributions to the field of medicinal chemistry and his innovative patent work highlight his role as a significant inventor. His ongoing research promises to impact the treatment of diseases positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile